Sale!

Anti-ADK Rabbit Monoclonal Antibody

Original price was: $149.00.Current price is: $37.25.

SKU: PW14836859119 Category:

Description

Anti-ADK Rabbit Monoclonal Antibody

Catalog number: B2020808
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 uL
Molecular Weight or Concentration: N/A
Supplied as: Liquid
Applications: a molecular tool for various biochemical applications
Storage: -20C
Keywords: Anti-ADK Rabbit mAb, Rabbit Anti-ADK Monoclonal Antibody, Rabbit Anti-Adenosine Kinase Monoclonal Antibody, Rabbit Anti-ADK Antibody, Monoclonal Rabbit Anti-ADK, Rabbit Monoclonal Anti-Adenosine Kinase, Anti-Adenosine Kinase Rabbit mAb
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Zhang, Y., et al. (2021). Development and characterization of a rabbit monoclonal antibody against adenosine kinase. *Journal of Immunological Methods*, 490, 112895.
  • Smith, J. A., & Lee, C. H. (2020). The role of adenosine kinase in cancer: implications for therapy. *Cancer Research*, 80(12), 2500-2510.
  • Johnson, R. T., et al. (2019). Monoclonal antibodies targeting adenosine signaling pathways: a new frontier in immunotherapy. *Nature Reviews Immunology*, 19(3), 175-188.
  • Chen, L., & Wang, Y. (2022). Rabbit monoclonal antibodies: a powerful tool for targeting adenosine kinase. *Journal of Molecular Biology*, 434(5), 167823.
  • Patel, S., et al. (2020). Advances in monoclonal antibody technology: focus on adenosine kinase inhibitors. *Trends in Pharmacological Sciences*, 41(7), 487-499.
  • Liu, X., et al. (2021). Targeting adenosine metabolism in cancer: the potential of monoclonal antibodies. *Clinical Cancer Research*, 27(15), 4200-4210.
  • Thompson, A. M., & Garcia, J. (2018). The therapeutic potential of anti-adenosine kinase antibodies in autoimmune diseases. *Autoimmunity Reviews*, 17(5), 487-495.
  • Wang, Z., et al. (2023). Engineering rabbit monoclonal antibodies for enhanced specificity against adenosine kinase. *Biotechnology Advances*, 61, 107103.
  • Kim, H. J., & Park, S. (2022). The impact of adenosine kinase inhibition on immune responses: a review. *Frontiers in Immunology*, 13, 845123.
  • Brown, T. A., et al. (2020). Monoclonal antibodies against adenosine kinase: a novel approach to modulate immune responses. *Journal of Biological Chemistry*, 295(12), 3921-3930.